Skip to main content

Exclusive news, data and analytics for financial market professionalsLearn more about

PositiveSPX4,109.311.44%Positive
PositiveIXIC12,221.911.74%Positive
PositiveDJI33,274.151.26%Positive
PositiveSTOXX457.840.66%Positive
PositiveFTSE7,631.740.15%Positive
PositiveN22528,041.480.93%Positive

Get real-time market data on Refinitiv

BMRN.O

BMRN.O

Official Data Partner

Latest Trade: trading lower--
Change; --; --

As of Mar 31 2023. Values delayed up to 15 minutes

Today's Range: -- - --
52 Week Range: -- - --

About (BMRN.O)

Company Information

Address

,

Contact Information

Industry

Latest News

BusinesscategorySarepta slides as FDA about-turn on panel clouds gene therapy approval path, article with galleryMarch 17, 2023
Future of HealthcategoryU.S. FDA extends review of BioMarin's bleeding disorder therapy, article with imageMarch 7, 2023
Healthcare & PharmaceuticalscategoryBioMarin drug becomes first U.S. approved therapy for dwarfism, article with imageNovember 19, 2021
WorldcategoryBiomarin's drug wins Europe's first approval for type of dwarfism
U.S.-based Biomarin Pharmaceutical Inc's treatment for one of the most common forms of dwarfism received clearance from the European Commission, becoming the first therapy to get an approval in the region for achondroplasia.
August 27, 2021

Markets Performance

Official Data Partner

Commodities

Future	Last	% Change
Gold	1,969.80	0.53%Negative
Copper	775.05	1.74%Negative
Brent Crude Oil	79.89	--
CBOT Soybeans	1,505.00	2.07%Positive

Currencies

Exchange	Last	% Change
EUR/USD	1.0836	--
GBP/USD	1.2333	--
JPY/USD	0.0075	--
CNY/USD	0.1456	--

Rates & Bonds

Name	Yield	Change
US 10Y	3.473	-0.078
DE 10Y	2.283	-0.027
UK 10Y	3.465	-0.025
JP 10Y	0.334	+0.01

Stocks

Index	Last	% Change
S&P 500	4,109.31	1.44%Positive
Euro STOXX 50	4,315.05	0.69%Positive
FTSE 100	7,631.74	0.15%Positive
Nikkei 225	28,041.48	0.93%Positive

Source: Refinitiv, an LSEG business - data delayed by at least 15 minutes